Senzo Health Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 23

Senzo Health General Information

Description

Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platform utilizes novel technologies to create mobile, point-of-care, and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing, enabling people to put healthcare information directly into their hands to improve their quality of life.

Contact Information

Website
www.senzo.com
Formerly Known As
Orphidia
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 64 Rochester Place
  • London NW1 9JX
  • England, United Kingdom
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 64 Rochester Place
  • London NW1 9JX
  • England, United Kingdom

Senzo Health Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Senzo Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 30-Jul-2024 $1.8M Completed Pre-Clinical Trials
6. Later Stage VC 12-Dec-2022 Completed Pre-Clinical Trials
5. Accelerator/Incubator 30-May-2021 Completed Product Development
4. Seed Round 26-Feb-2018 Completed Product Development
3. Accelerator/Incubator 07-Aug-2017 Completed Product Development
2. Seed Round 16-Mar-2016 $1.27M $1.32M Completed Product Development
1. Accelerator/Incubator 15-May-2015 $50K $50K Completed Product Development
To view Senzo Health’s complete valuation and funding history, request access »

Senzo Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-3
Seed 2,618,610 $0.000100 $0.41 $0.41 1x $0.41 14.05%
To view Senzo Health’s complete cap table history, request access »

Senzo Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platfor
Other Devices and Supplies
London, United Kingdom
20 As of 2024

San Diego, CA
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Senzo Health Competitors (7)

One of Senzo Health’s 7 competitors is Genalyte, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genalyte Venture Capital-Backed San Diego, CA
Lucira Health Formerly VC-backed Emeryville, CA
Abbott Diagnostics Failed Transaction (M&A) Lake Forest, IL
QuidelOrtho Corporation San Diego, CA
LumiraDx Formerly VC-backed London, United Kingdom
You’re viewing 5 of 7 competitors. Get the full list »

Senzo Health Patents

Senzo Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230062903-A1 High sensitivity analyte network detection flow assays and related methods Pending 11-Aug-2021
US-20230194518-A1 High sensitivity analyte network detection flow assays and related methods Pending 11-Aug-2021
CA-3228664-A1 High sensitivity analyte network detection flow assays and related methods Pending 11-Aug-2021
EP-4384826-A1 High sensitivity analyte network detection flow assays and related methods Pending 11-Aug-2021
US-20210231648-A1 Linker molecule for treating a substrate surface Pending 17-Jul-2015 G01N33/547
To view Senzo Health’s complete patent history, request access »

Senzo Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Senzo Health Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lombardstreet Ventures Venture Capital Minority
Ramp Health PE-Backed Company Minority
MedTech Innovator Accelerator/Incubator
Advisors.Fund Venture Capital Minority
Ataria Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Senzo Health FAQs

  • When was Senzo Health founded?

    Senzo Health was founded in 2013.

  • Where is Senzo Health headquartered?

    Senzo Health is headquartered in London, United Kingdom.

  • What is the size of Senzo Health?

    Senzo Health has 20 total employees.

  • What industry is Senzo Health in?

    Senzo Health’s primary industry is Other Devices and Supplies.

  • Is Senzo Health a private or public company?

    Senzo Health is a Private company.

  • What is Senzo Health’s current revenue?

    The current revenue for Senzo Health is .

  • How much funding has Senzo Health raised over time?

    Senzo Health has raised $9.8M.

  • Who are Senzo Health’s investors?

    Lombardstreet Ventures, Ramp Health, MedTech Innovator, Advisors.Fund, and Ataria are 5 of 23 investors who have invested in Senzo Health.

  • Who are Senzo Health’s competitors?

    Genalyte, Lucira Health, Abbott Diagnostics, QuidelOrtho, and LumiraDx are some of the 7 competitors of Senzo Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »